|
Post by awesomo on May 21, 2019 8:14:54 GMT -5
No news and volume is very low, probably someone just playing games as it did get picked up on some radars for premarket movers.
|
|
|
Post by liane on May 21, 2019 8:25:12 GMT -5
I think it's just someone buying at market and disregarding the illiquidity.
|
|
|
Post by cretin11 on May 21, 2019 11:29:26 GMT -5
i think liane nailed it. we have seen this from time to time and have learned not to "fall for it" in terms of it meaning anything.
|
|
|
Post by peppy on May 21, 2019 11:45:26 GMT -5
i think liane nailed it. we have seen this from time to time and have learned not to "fall for it" in terms of it meaning anything. No volume, 284,067 shares traded real time at the half.
|
|
|
Post by seanismorris on May 21, 2019 11:48:55 GMT -5
i think liane nailed it. we have seen this from time to time and have learned not to "fall for it" in terms of it meaning anything. I means we’re following MNKD to closely. We have a total movement of 3 pennies on no volume. Check back in on Friday, unless there is a press release...
|
|
|
Post by mytakeonit on May 21, 2019 14:36:09 GMT -5
I think it's just someone buying at market and disregarding the illiquidity. Ahhh ... to be young and foolish again. Those were the days ... the Yay !!! and Aarrrgghhh !!! Days. Or Daze ... But, that's mytakeonit
|
|
|
Post by joeypotsandpans on May 24, 2019 11:40:06 GMT -5
i think liane nailed it. we have seen this from time to time and have learned not to "fall for it" in terms of it meaning anything. No volume, 284,067 shares traded real time at the half. Each selloff over the last 5 yrs. is on weaker and weaker strength which is evident via the divergence with the higher lows on relative strength (lower chart) and relative flat line in price (upper chart). Conversely, if you look at the last spike in volume (last green bar in the volume chart (middle chart) the corresponding peak in relative strength reached a higher high compared to the previous price jumps....I am expecting this to play out and be resolved with a breakout to upside as the equity is pretty washed out at this point with a higher high in relative strength. Take it fwiw, accumulation at these levels looks pretty attractive, JMHO. Enjoy the holiday weekend and good luck Conor!!
|
|
|
Post by radgray68 on May 24, 2019 20:37:26 GMT -5
No volume, 284,067 shares traded real time at the half. Each selloff over the last 5 yrs. is on weaker and weaker strength which is evident via the divergence with the higher lows on relative strength (lower chart) and relative flat line in price (upper chart). Conversely, if you look at the last spike in volume (last green bar in the volume chart (middle chart) the corresponding peak in relative strength reached a higher high compared to the previous price jumps....I am expecting this to play out and be resolved with a breakout to upside as the equity is pretty washed out at this point with a higher high in relative strength. Take it fwiw, accumulation at these levels looks pretty attractive, JMHO. Enjoy the holiday weekend and good luck Conor!! I would add that the momentum indicator, using a 30 day cycle, shows we are back down to where we were the last two times we got pushed down near $1, telling me there's not much room left to go the downside. In other words, bottom is pretty much in, safe to accumulate again.
|
|
|
Post by awesomo on May 28, 2019 13:19:42 GMT -5
So we're pretty much back at the levels before the UTHR partnership and after the December dilution. Every day seems to just bleed out a little more on low volume. Management seems to be in a "wait and see" mode for Q2, which is probably why the stock is being completely ignored in terms of buying interest.
Where do we go from here? The downside as of now seems limited at this point, but the threat of dilution grows with each passing week given the weak-at-best Afrezza revenue/script growth. Unfortunately, a dilution+warrants at this level would probably sink us for good.
Management better pull out another UTHR-type partnership soon or another magic "$6 raise".
|
|
|
Post by factspls88 on May 28, 2019 14:23:29 GMT -5
So we're pretty much back at the levels before the UTHR partnership and after the December dilution. Every day seems to just bleed out a little more on low volume. Management seems to be in a "wait and see" mode for Q2, which is probably why the stock is being completely ignored in terms of buying interest. Where do we go from here? The downside as of now seems limited at this point, but the threat of dilution grows with each passing week given the weak-at-best Afrezza revenue/script growth. Unfortunately, a dilution+warrants at this level would probably sink us for good. Management better pull out another UTHR-type partnership soon or another magic "$6 raise". Where do we go to from here? To the liquor cabinet for a drink. Relentless downside. This is exhausting.
|
|
|
Post by ktim on May 28, 2019 14:38:48 GMT -5
So we're pretty much back at the levels before the UTHR partnership and after the December dilution. Every day seems to just bleed out a little more on low volume. Management seems to be in a "wait and see" mode for Q2, which is probably why the stock is being completely ignored in terms of buying interest. Where do we go from here? The downside as of now seems limited at this point, but the threat of dilution grows with each passing week given the weak-at-best Afrezza revenue/script growth. Unfortunately, a dilution+warrants at this level would probably sink us for good. Management better pull out another UTHR-type partnership soon or another magic "$6 raise". Though using TrepT as a model, we'd know of such an API being pushed through the pipeline by MNKD well ahead of a partnership deal that came with money. Not to say something out of the blue is impossible, but the history of MNKD has two models... develop an API to a certain level and get upfront money from a partnership (UTHR or SNY) or partner early and get little or nothing doing the deal (several examples). Currently the pipeline only contains APIs at the starting gate.
|
|
|
Post by matt on May 28, 2019 15:01:59 GMT -5
So we're pretty much back at the levels before the UTHR partnership and after the December dilution. Every day seems to just bleed out a little more on low volume. Management seems to be in a "wait and see" mode for Q2, which is probably why the stock is being completely ignored in terms of buying interest. I don't think management is in wait and see mode; the quarter is almost two-thirds over and they have a pretty good idea at this point whether the numbers will be up, down, or about the same. What we might be seeing is some ATM sales hitting the market causing the slow decline in PPS. Rule 415 offerings (the ATM is one form of that) only have to be disclosed once per quarter so there will be no news on that until the middle of August, but that is what the dribble down feels like. As for the pipeline, I don't think anybody should get too excited about pipeline candidates that are generic drugs as the competition model there is not going to be favorable to TS formulations. When a major player like UTHR has a drug coming to the end of its protected life, putting a new formulation into the market to extend exclusivity is a great play for that manufacturer and that is why UTHR was willing to write a decent sized check. I can only hope that Mike and friends have scrubbed the list of drug currently patent protected with sunset dates coming in the next five years; that list might have the next UTHR on it.
|
|
|
Post by sportsrancho on May 28, 2019 15:57:42 GMT -5
IMO they are using the ATM to pay off Deerfield. So we may be bleeding for another month.
|
|
|
Post by brotherm1 on May 28, 2019 16:03:37 GMT -5
IMO they are using the ATM to pay off Deerfield. So we may be bleeding for another month. What would be the logic for that Sports?
|
|
|
Post by sportsrancho on May 28, 2019 16:05:21 GMT -5
IMO they are using the ATM to pay off Deerfield. So we may be bleeding for another month. What would be the logic for that Sports? To preserve cash?
|
|